Emergent BioSolutions Announces 2022 Financial Guidance, Provides Preliminary 2021
Expects a re-baseline of operations with stable revenue contributions from core products and services business in 2022, guiding to total revenues of $1.45 billion at the midpoint and Adjusted EBITDA margin of 21.5% at the midpointReports…